Gossamer Bio Stock Market Value
| GOSS Stock | USD 0.42 0.02 5.00% |
| Symbol | Gossamer |
Is there potential for Biotechnology market expansion? Will Gossamer introduce new products? Factors like these will boost the valuation of Gossamer Bio. Market participants price Gossamer higher when confident in its future expansion prospects. Understanding fair value requires weighing current performance against future potential. All the valuation information about Gossamer Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.69) | Revenue Per Share | Quarterly Revenue Growth 0.402 | Return On Assets | Return On Equity |
Investors evaluate Gossamer Bio using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Gossamer Bio's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. External factors like market trends, sector rotation, and investor psychology can cause Gossamer Bio's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Gossamer Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Gossamer Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Gossamer Bio's market price signifies the transaction level at which participants voluntarily complete trades.
Gossamer Bio 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Gossamer Bio's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Gossamer Bio.
| 11/30/2025 |
| 02/28/2026 |
If you would invest 0.00 in Gossamer Bio on November 30, 2025 and sell it all today you would earn a total of 0.00 from holding Gossamer Bio or generate 0.0% return on investment in Gossamer Bio over 90 days. Gossamer Bio is related to or competes with Kalvista Pharmaceuticals, 4D Molecular, Olema Pharmaceuticals, Ventyx Biosciences, Lexicon Pharmaceuticals, Rigel Pharmaceuticals, and Prothena Plc. Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and comme... More
Gossamer Bio Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Gossamer Bio's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Gossamer Bio upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.16) | |||
| Maximum Drawdown | 94.66 | |||
| Value At Risk | (7.87) | |||
| Potential Upside | 7.66 |
Gossamer Bio Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Gossamer Bio's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Gossamer Bio's standard deviation. In reality, there are many statistical measures that can use Gossamer Bio historical prices to predict the future Gossamer Bio's volatility.| Risk Adjusted Performance | (0.11) | |||
| Jensen Alpha | (1.97) | |||
| Total Risk Alpha | (2.80) | |||
| Treynor Ratio | (0.42) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Gossamer Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Gossamer Bio February 28, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.11) | |||
| Market Risk Adjusted Performance | (0.41) | |||
| Mean Deviation | 5.23 | |||
| Coefficient Of Variation | (668.69) | |||
| Standard Deviation | 10.99 | |||
| Variance | 120.88 | |||
| Information Ratio | (0.16) | |||
| Jensen Alpha | (1.97) | |||
| Total Risk Alpha | (2.80) | |||
| Treynor Ratio | (0.42) | |||
| Maximum Drawdown | 94.66 | |||
| Value At Risk | (7.87) | |||
| Potential Upside | 7.66 | |||
| Skewness | (5.72) | |||
| Kurtosis | 41.18 |
Gossamer Bio Backtested Returns
Gossamer Bio holds Efficiency (Sharpe) Ratio of -0.16, which attests that the entity had a -0.16 % return per unit of risk over the last 3 months. Gossamer Bio exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Gossamer Bio's Market Risk Adjusted Performance of (0.41), risk adjusted performance of (0.11), and Standard Deviation of 10.99 to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 3.95, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Gossamer Bio will likely underperform. At this point, Gossamer Bio has a negative expected return of -1.83%. Please make sure to check out Gossamer Bio's treynor ratio, accumulation distribution, as well as the relationship between the Accumulation Distribution and period momentum indicator , to decide if Gossamer Bio performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.75 |
Good predictability
Gossamer Bio has good predictability. Overlapping area represents the amount of predictability between Gossamer Bio time series from 30th of November 2025 to 14th of January 2026 and 14th of January 2026 to 28th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Gossamer Bio price movement. The serial correlation of 0.75 indicates that around 75.0% of current Gossamer Bio price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.75 | |
| Spearman Rank Test | 0.64 | |
| Residual Average | 0.0 | |
| Price Variance | 0.59 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Gossamer Stock Analysis
When running Gossamer Bio's price analysis, check to measure Gossamer Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gossamer Bio is operating at the current time. Most of Gossamer Bio's value examination focuses on studying past and present price action to predict the probability of Gossamer Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gossamer Bio's price. Additionally, you may evaluate how the addition of Gossamer Bio to your portfolios can decrease your overall portfolio volatility.